Breaking News Instant updates and real-time market news.

BLRX

BioLineRx

$0.88

0.0131 (1.50%)

07:11
08/07/18
08/07
07:11
08/07/18
07:11

BioLineRx says 'extremely encouraged' by lead-in period of Phase 3 GENESIS trial

BioLineRx announced results from the lead-in period of the GENESIS trial, a double-blind, placebo-controlled Phase 3 trial comparing BL-8040 in combination with granulocyte colony-stimulating factor, to G-CSF alone, for the mobilization of hematopoietic stem cells used for autologous transplantation in multiple myeloma patients. The open-label, single-arm, lead-in period of the study was designed to include up to 30 patients, with Data Monitoring Committee review after completion of approximately 10, 20 and 30 patients, in order to assess safety and efficacy following treatment with BL-8040 plus G-CSF. Results of the first 11 patients show that BL-8040 in combination with standard G-CSF treatment is safe and tolerable. In addition, the data show that 9/11 patients reached the primary endpoint threshold of greater than or equal to 6x106 CD34 cells/kg with only one dose of BL-8040 and in up to 2 apheresis sessions. Furthermore, 7/11 patients reached the threshold of greater than or equal to 6x106 CD34 cells/kg in a single apheresis session only. These data demonstrate the potential of BL-8040 treatment to reduce the number of administrations and apheresis sessions, as well as hospitalization costs, related to the preparation of multiple myeloma patients for autologous HSC transplantation. "We are extremely encouraged by these results. Based on the robust data received from the first 11 patients, the DMC issued a positive recommendation to stop the lead-in part of the study and move immediately to the randomized placebo-controlled part of the study. This is the first Phase 3 trial for our lead BL-8040 program, and as such, it is an important milestone in BL-8040's comprehensive development plan. We look forward to the top-line results from the randomized, double-blind, placebo-controlled part of the study, which are expected in 2020," stated Philip Serlin, Chief Executive Officer of BioLineRx.

  • 13

    Aug

BLRX BioLineRx
$0.88

0.0131 (1.50%)

03/06/18
HCWC
03/06/18
NO CHANGE
HCWC
H.C. Wainwright sees several second half data catalysts for BioLineRx
H.C. Wainwright analyst Joseph Pantginis noted that BioLineRx's Q4 and FY17 financial results missed the firm's estimates slightly, but he was optimistic about the company's second half data catalysts -- including topline results from COMBAT, lead-in stage results for the Phase 3 GENESIS study, partial results from Phase 1b/2 studies for BL-8040 in combination with Tecentriq in gastric cancer, NSCLC, and AML, as well as data from multiple other studies. Pantginis reiterated a Buy rating and has a $4 price target on BioLineRx shares.

TODAY'S FREE FLY STORIES

XPO

XPO Logistics

$78.25

-0.65 (-0.82%)

11:25
11/15/18
11/15
11:25
11/15/18
11:25
Options
XPO Logistics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHVN

Biohaven Pharmaceutical

$32.50

-1.2 (-3.56%)

11:25
11/15/18
11/15
11:25
11/15/18
11:25
Conference/Events
Biohaven Pharmaceutical management to meet with Morgan Stanley »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 27

    Nov

EVFM

Evofem

$3.44

(0.00%)

11:25
11/15/18
11/15
11:25
11/15/18
11:25
Conference/Events
Evofem to hold a key opinion leader event »

Management hosts a Key…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 16

    Nov

  • 19

    Nov

  • 27

    Nov

11:25
11/15/18
11/15
11:25
11/15/18
11:25
Conference/Events
Morgan Stanley healthcare analysts to hold a luncheon »

Healthcare Analysts host…

SPLK

Splunk

$99.00

1.15 (1.18%)

, SAP

SAP

$104.09

0.23 (0.22%)

11:25
11/15/18
11/15
11:25
11/15/18
11:25
Conference/Events
Wedbush enterprise software analyst to hold a luncheon »

Enterprise Software…

SPLK

Splunk

$99.00

1.15 (1.18%)

SAP

SAP

$104.09

0.23 (0.22%)

ORCL

Oracle

$49.62

0.78 (1.60%)

PANW

Palo Alto Networks

$171.57

-5.26 (-2.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 19

    Nov

  • 26

    Nov

  • 29

    Nov

  • 29

    Nov

  • 05

    Dec

  • 06

    Dec

  • 10

    Dec

  • 09

    Jan

  • 10

    Jan

11:25
11/15/18
11/15
11:25
11/15/18
11:25
Conference/Events
RBC Capital software analysts to hold a group luncheon »

Software Analysts Hedberg…

LOXO

Loxo Oncology

$147.40

3.71 (2.58%)

11:25
11/15/18
11/15
11:25
11/15/18
11:25
Conference/Events
Loxo Oncology management to meet with Morgan Stanley »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 26

    Nov

  • 27

    Nov

MO

Altria Group

$58.61

-0.48 (-0.81%)

, BTI

British American Tobacco

$35.55

-0.96 (-2.63%)

11:22
11/15/18
11/15
11:22
11/15/18
11:22
Hot Stocks
CVS 'applauds' FDA announcement to restrict flavored tobacco products »

CVS Health (CVS)…

MO

Altria Group

$58.61

-0.48 (-0.81%)

BTI

British American Tobacco

$35.55

-0.96 (-2.63%)

PM

Philip Morris

$85.26

-0.25 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:20
11/15/18
11/15
11:20
11/15/18
11:20
General news
Energy Action: NYMEX crude »

Energy Action: NYMEX…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
11/15/18
11/15
11:17
11/15/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
11/15/18
11/15
11:16
11/15/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$34.69

0.46 (1.34%)

, QRVO

Qorvo

$63.65

0.77 (1.22%)

11:15
11/15/18
11/15
11:15
11/15/18
11:15
OnTheFly
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's top…

MYL

Mylan

$34.69

0.46 (1.34%)

QRVO

Qorvo

$63.65

0.77 (1.22%)

LITE

Lumentum

$39.14

0.29 (0.75%)

AAPL

Apple

$188.37

1.56 (0.84%)

ATNX

Athenex

$10.80

0.52 (5.06%)

PCG

PG&E

$19.54

-6.12 (-23.85%)

HZNP

Horizon Pharma

$20.53

-0.7 (-3.30%)

PYPL

PayPal

$84.29

0.24 (0.29%)

WP

Worldpay

$82.00

-0.71 (-0.86%)

FDC

First Data

$18.00

0.17 (0.95%)

SQ

Square

$70.75

0.9 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 26

    Nov

  • 27

    Nov

  • 12

    Dec

  • 18

    Dec

  • 18

    Dec

  • 03

    Mar

MTOR

Meritor

$15.36

-1.95 (-11.27%)

11:12
11/15/18
11/15
11:12
11/15/18
11:12
Recommendations
Meritor analyst commentary  »

Meritor earnings report…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 13

    Dec

AAPL

Apple

$188.71

1.9 (1.02%)

, LITE

Lumentum

$39.27

0.42 (1.08%)

11:12
11/15/18
11/15
11:12
11/15/18
11:12
OnTheFly
Morgan Stanley says buy Apple on any weakness amid supply chain ‘noise’ »

Calling the recent…

AAPL

Apple

$188.71

1.9 (1.02%)

LITE

Lumentum

$39.27

0.42 (1.08%)

QRVO

Qorvo

$63.84

0.96 (1.53%)

GLW

Corning

$31.59

0.18 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

KBH

KB Home

$17.07

-3.73 (-17.93%)

11:10
11/15/18
11/15
11:10
11/15/18
11:10
Options
KB Home puts lead calls 4:1 and implied volatility spikes to 52-week highs »

KB Home puts lead calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:01
11/15/18
11/15
11:01
11/15/18
11:01
General news
Crude inventories for week of November 9 »

Crude oil inventories…

AUY

Yamana Gold

$2.14

0.015 (0.71%)

11:00
11/15/18
11/15
11:00
11/15/18
11:00
Options
Volatility play in Yamana Gold »

Volatility play in Yamana…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AWI

Armstrong World

$64.99

-1.01 (-1.53%)

10:55
11/15/18
11/15
10:55
11/15/18
10:55
Conference/Events
Armstrong World to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 16

    Nov

CLSN

Celsion

$1.99

-0.08 (-3.86%)

10:55
11/15/18
11/15
10:55
11/15/18
10:55
Conference/Events
Celsion to hold a conference call »

Conference Call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

FOXA

21st Century Fox

$47.66

-0.27 (-0.56%)

10:52
11/15/18
11/15
10:52
11/15/18
10:52
Hot Stocks
FOX Sports, Major League Baseball reach new multi-year agreement »

FOX Sports and Major…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

M

Macy's

$31.89

-1.32 (-3.97%)

10:50
11/15/18
11/15
10:50
11/15/18
10:50
Options
Second day of big option prints in Macy's »

Second day of big option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$99.47

-2.11 (-2.08%)

10:49
11/15/18
11/15
10:49
11/15/18
10:49
Periodicals
Sanders bill would prevent stock buybacks unless companies pay $15/hr, CNBC says »

Senator Bernie Sanders is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

GPRE

Green Plains

$16.94

-0.23 (-1.34%)

, GPP

Green Plains Partners

$14.68

(0.00%)

10:46
11/15/18
11/15
10:46
11/15/18
10:46
Hot Stocks
Green Plains announces permanent closure of Hopewell, VA ethanol facility »

Green Plains (GPRE)…

GPRE

Green Plains

$16.94

-0.23 (-1.34%)

GPP

Green Plains Partners

$14.68

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
11/15/18
11/15
10:45
11/15/18
10:45
General news
Breaking General news story  »

6-Month Bill Announcement…

10:45
11/15/18
11/15
10:45
11/15/18
10:45
General news
Breaking General news story  »

Federal Reserve Chairman…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.